4/A
Changes in Ownership
ANI PHARMACEUTICALS INC Filed Acc 0001104659-23-074399
HEAD OF R&D, COO-NOVITIUM OPS sold 50,000 shares at an average $51.70 ($2,584,912)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Shanmugam Muthusamy · HEAD OF R&D, COO-NOVITIUM OPS
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-20 | Sale : show line 1 in the form 10b5-1 | −14,657 | $51.93 | $761,138 | 1,317,963 | I |
| 2023-06-21 | Sale : show line 2 in the form 10b5-1 | −11,843 | $51.95 | $615,244 | 1,306,120 | I |
| 2023-06-22 | Sale : show line 3 in the form 10b5-1 | −13,500 | $51.38 | $693,630 | 1,292,620 | I |
| 2023-06-23 | Sale : show line 4 in the form 10b5-1 | −10,000 | $51.49 | $514,900 | 1,282,620 | I |
| Open-market sales · 50,000 sh · avg $51.70 · $2,584,912 | ||||||
Loading xslF345X04/tm2319615-2_4aseq1.xml…